Abstract
Purpose
Gestational diabetes mellitus (GDM), a state of glucose intolerance associated with pregnancy, is increasing in prevalence. Data regarding the cancer risk associated with GDM are sparse and limited to cancers of the breast and pancreas. This study was conducted to examine the risk of incident overall and site-specific malignancies associated with prior GDM in a historical cohort of women in a large health maintenance organization in Israel.
Methods
All pregnant women aged 15–50 years who underwent 50-g glucose challenge tests between 13 March 1995 and 27 May 2009, without history of malignancy, diabetes, and infertility, were included. Clinical and demographic parameters at index date including age, socioeconomic level, BMI, and parity were collected. Diagnosis of gestational diabetes was based on the 100-g oral glucose tolerance test using Carpenter and Coustan criteria. Cancer diagnoses were obtained from the Israel Cancer Register through linkage data.
Results
Among the 185,315 women who had undergone glucose challenge during the study period, 11,264 (6.1%) were diagnosed with GDM. During a total follow-up period of 1.05 million person-years (mean = 5.19 ± 3.9, median = 4.3), 2,034 incident cases of cancer were identified. GDM was associated with a hazard ratio (HR) of 7.06 (95% CI: 1.69–29.45) for pancreatic cancer (nine cases) and a HR of 1.70 (95% CI: 0.97–2.99) for hematological malignancies (177 cases). The association between GDM and hematological malignancies was limited to women with 5 or more years of follow-up (HR = 4.53; 95% CI: 1.81–11.31).
Conclusion
GDM is associated with an increased risk of pancreatic cancer and hematologic malignancies.
Similar content being viewed by others
Abbreviations
- GDM:
-
Gestational diabetes mellitus
- DM:
-
Diabetes mellitus
- GCT:
-
Glucose challenge test
- OGTT:
-
Oral glucose tolerance test
- HMO:
-
Health maintenance organization
- MHS:
-
Maccabi healthcare services
- NHL:
-
Non-hodgkin’s lymphoma
- AML:
-
Acute myeloid leukemia
References
Metzger BE, Coustan DR (1998) Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. The organizing committee. Diabetes Care 21(Suppl 2):B161–B167
Buchanan TA, Xiang A, Kjos SL, Watanabe R (2007) What is gestational diabetes? Diabetes Care 30(Suppl 2):S105–S111
Ferrara A, Hedderson MM, Quesenberry CP, Selby JV (2002) Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the carpenter and coustan plasma glucose thresholds. Diabetes Care 25(9):1625–1630
Dornhorst A, Paterson CM, Nicholls JS, Wadsworth J, Chiu DC, Elkeles RS, Johnston DG, Beard RW (1992) High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 9(9):820–825
Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS (2005) Increasing prevalence of gestational diabetes (GDM) over time and by birth cohort: Kaiser Permanente of colorado GDM screening program. Diabetes Care 28(3):579–584
Ferrara A (2007) Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30(Suppl 2):S141–S146
Kjos SL, Buchanan TA (1999) Gestational diabetes mellitus. N Engl J Med 341(23):1749–1756
Metzger BE (2007) Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 50(4):972–979
Chodick G, Elchalal U, Sella T, Heymann A, Porath A, Kokia E, Shalev V (2010) The risk of overt diabetes mellitus among women with gestational diabetes: a population-based study. Diabet Med 27(7):779–785
Saydah SH, Loria CM, Eberhardt MS, Brancati FL (2003) Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 157(12):1092–1100
Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293(2):194–202
Zhou XH, Qiao Q, Zethelius B, Pyörälä K, Söderberg S, Pajak A, Stehouwer CD, Heine RJ, Jousilahti P, Ruotolo G, Nilsson PM, Calori G, Tuomilehto J, The DECODE Study Group (2010) Diabetes, prediabetes and cancer mortality. Diabetologia 53(9):1867–1876
Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159(12):1160–1167
Chodick G, Heymann A, Rosenmann L, Green M, Flash S, Porath A, Kokia E, Shalev V (2010) Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 21(6):879–887
Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273(20):1605–1609
Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, Persson I (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2(5):307–314
La Vecchia C, Negri E, Franceschi S, D’Avanzo B, Boyle P (1994) A case–control study of diabetes mellitus and cancer risk. Br J Cancer 70(5):950–953
Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86(3):S823–S835
Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomark Prev 11(11):1361–1368
Adler AI, Weiss NS, Kamb ML, Lyon JL (1996) Is diabetes mellitus a risk factor for ovarian cancer? A case–control study in Utah and Washington (United States). Cancer Causes Control 7(4):475–478
Dawson S (2004) Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer 100(1):149–155
Perrin M, Terry M, Kleinhaus K, Yanetz R, Tiram E, Calderon-Margalit R, Friedlander Y, Paltiel O, Harlap S (2008) Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study. Breast Cancer Res Treat 108(1):129–135
Perrin MC, Terry MB, Kleinhaus K, Deutsch L, Yanetz R, Tiram E, Calderon R, Friedlander Y, Paltiel O, Harlap S (2007) Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study. BMC Med 5:25. doi:1741-7015-5-25
Nechuta S, Paneth N, Velie E (2010) Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control 21(7):967–989
Bendelac J (2009) Membership in sick funds 2008. National Insurance Institute, Jerusalem
Chodick G, Heymann A, Shalev V, Kookia E (2003) The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol 18:1143–1146
American Diabetes Association (2003) Gestational diabetes mellitus. Diabetes Care 26(Suppl 1):S103–S105
Carpenter M, Coustan D (1982) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144:768–773
Israel Center for Disease Control (2003) Investigation into the completeness for the Israel cancer registry. Israel Center for Disease Control Publication 230 (In Hebrew), Jerusalem
World Health Organization (1998) Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity, 3–5 June 1997. World Health Organization, Geneva, Switzerland
Israel Central Bureau of Statistics (1998) 1995 Census of population and housing, Jerusalem
Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 32:187–220
Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076–2083
Karna E, Surazynski A, Orlowski K, Laszkiewicz J, Puchalski Z, Nawrat P, Palka J (2002) Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer. Int J Exp Pathol 83(5):239–245
Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M (1995) Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55(10):2007–2011
Li D, Abbruzzese JL (2010) New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts. Clin Cancer Res 16(17):4313–4318
Lisker S, Brody J, Beizer L (1966) Abnormal carbohydrate metabolism in patients with malignant blood dyscrasias. Am J Med Sci 252:282–288
Mitri J, Castillo J, Pittas A (2008) Diabetes and risk of non-Hodgkin’s lymphoma: a meta-analysis of observational studies. Diabetes Care 31:2391–2397
PJ ChaoC (2008) Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis. Am J Epidemiol 168(5):471–480
Cerhan J, Wallace R, Folsom A, Potter J, Sellers T, Zheng W, Lutz C (1997) Medical history risk factors for non-Hodgkin’s lymphoma in older women. J Natl Cancer Inst 89(4):314–318
Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes—a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241(6):471–475
Cerhan JR, Bernstein L, Severson RK, Davis S, Colt JS, Blair A, Hartge P (2005) Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control 16(10):1203–1214
Troisi R, Weiss H, Hoover R (1998) Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9(6):641–647
Rollison DE, Giuliano AR, Sellers TA, Laronga C, Sweeney C, Risendal B, Baumgartner KB, Byers T, Slattery ML (2008) Population-based case–control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol 167(4):447–456
Haver M, Locksmith G, Emmet E (2003) Irregular menses: an independent risk factor for gestational diabetes mellitus. Am J Obstet Gynecol 188(5):1189–1191
Clavel-Chapelon F, E3N Group (2002) Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 13(9):831–838
Bassett JK, Severi G, English DR, Baglietto L, Krishnan K, Hopper JL, Giles GG (2010) Body size, weight change, and risk of colon cancer. Cancer Epidemiol Biomark Prev 19(11):2978–2986
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578
U.S. Cancer Statistics Working Group (2010) United States cancer statistics: 1999–2006 incidence and mortality web-based report. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, US
American Cancer Society (2010) Cancer facts and figures 2010. American Cancer Society, Atlanta, GA
Conflict of interests
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Tal Sella and Gabriel Chodick equally contributed to the study and manuscript.
Rights and permissions
About this article
Cite this article
Sella, T., Chodick, G., Barchana, M. et al. Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel. Cancer Causes Control 22, 1513–1520 (2011). https://doi.org/10.1007/s10552-011-9825-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-011-9825-5